Division of Nephrology, Department of Medicine and the Kidney Research Institute, University of Washington, 1959 NE Pacific St, Campus Box 356521, Seattle, WA, 98195, USA.
Department of Anthropology, University of Toronto, Toronto, Canada.
BMC Nephrol. 2020 Jul 25;21(1):300. doi: 10.1186/s12882-020-01951-1.
A potential pitfall of policies intended to promote referral for kidney transplant is that greater numbers of patients may be evaluated for transplant without experiencing the intended benefit of receiving a kidney. Little is known about the potential implications of this experience for patients.
We performed a thematic analysis of clinician documentation in the electronic medical records of all adults at a single medical center with advanced kidney disease who were referred to the local transplant coordinator for evaluation between 2008 and 2018 but did not receive a kidney.
148 of 209 patients referred to the local kidney transplant coordinator at our center (71%) had not received a kidney by the end of follow-up. Three dominant themes emerged from qualitative analysis of documentation in the medical records of these patients: 1) Forward momentum: patients found themselves engaged in an iterative process of testing and treatment that tended to move forward unless an absolute contraindication to transplant was identified or patients disengaged; 2) Potential for transplant shapes other medical decisions: engagement in the transplant evaluation process could impact many other aspects of patients' care; and 3) Personal responsibility and psychological burden for patients and families: clinician documentation suggested that patients felt personally responsible for the course of their evaluation and that the process could take an emotional toll on them and their family members.
Engagement in the kidney transplant evaluation process can be a significant undertaking for patients and families and may impact many other aspects of their care. Policies to promote referral for kidney transplant should be coupled with efforts to strengthen shared decision-making to ensure that the decision to undergo transplant evaluation is framed as an explicit choice with benefits, risks, and alternatives and patients have an opportunity to shape their involvement in this process.
旨在促进肾脏移植转诊的政策可能存在一个潜在的问题,即更多的患者可能会接受移植评估,但却无法获得预期的受益。对于这种经历对患者可能产生的潜在影响,我们知之甚少。
我们对 2008 年至 2018 年间在一家医疗中心就诊的患有晚期肾病且被转诊给当地移植协调员评估但未接受肾脏移植的所有成年人的电子病历中的临床医生记录进行了主题分析。
在我们中心,209 名被转诊给当地肾脏移植协调员的患者中(71%),在随访结束时没有接受肾脏移植。对这些患者的病历记录进行定性分析后,出现了三个主要主题:1)前进的动力:患者发现自己参与了一个测试和治疗的迭代过程,除非发现移植的绝对禁忌症或患者不再参与,否则该过程往往会向前推进;2)移植的潜力塑造了其他医疗决策:参与移植评估过程可能会影响患者护理的许多其他方面;3)患者及其家属的个人责任和心理负担:临床医生的记录表明,患者感到对自己的评估过程负有个人责任,并且该过程可能会对他们及其家庭成员造成情感上的影响。
参与肾脏移植评估过程对患者及其家属来说是一项重大的任务,并且可能会影响他们护理的许多其他方面。促进肾脏移植转诊的政策应该与加强共同决策的努力相结合,以确保接受移植评估的决定被框定为一个具有明确获益、风险和替代方案的明确选择,并且患者有机会塑造自己在这个过程中的参与度。